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Available online 12 November 2018Purpose: Themajority of peoplewith schizophrenia has impaired insight, which is related to a poorer outcome. In
this study, we evaluate a new psychosocial intervention ‘REFLEX’ aimed at improving insight in people with
schizophrenia. REFLEX focuses on targeting stigma-sensitivity, perspective taking and self-reflection in people
with schizophrenia and low insight. Primary objective is to improve insight and subsequently to improve func-
tional outcome and symptoms.
Method: A total of 121 people diagnosed with schizophrenia according to DSM IV criteria with impaired insight
was included in 2012–2015 from seven sites in amulticenter randomized controlled trial. REFLEXwas compared
to an active control condition consisting of group-wise simplified cognitive remediation training. Primary out-
come of the study were the preconditions of insight: internalized stigma, self-reflection, mental flexibility and
perspective taking. Clinical insight and cognitive insight were secondary outcomes.
Results: Although perspective taking, self-reflection, mental flexibility and stigma sensitivity remained un-
changed after the intervention, results showed a significant improvement of clinical insight in both conditions
directly after treatment (SAI-E Rater, p b .001, PANSS G12, p b .005) and at follow-up (SAI-E Rater, p b .01, SAI-
E interview, p b .001, PANSS G12, p b .0001). Improvement of clinical insight directly after treatment was larger
in the REFLEX condition (SAI-E Rater, p b .05). Other outcomes (self-esteem, quality of life and depression)
remained unchanged.
Conclusion: Though insight improved in both conditions, REFLEXwas not superior to simplifieddrill-and-practice
cognitive remediation training. Nevertheless, this study indicates that structured interventions can significantly
improve insight. Further research on the underlying mechanisms of both conditions is needed, as insight is un-
likely to improve spontaneously in chronic patients.







Many individuals with schizophrenia show a striking lack of insight
into their condition (Dam, 2006). Poor insight has negative associations
with many relevant outcomes of schizophrenia such as self-esteem,
mood and quality of life (Stefanopoulou et al., 2009; Drake et al.,Number: ISRCTN50247539.
niversity of Groningen, Grote
nborg).2007; Lincoln et al., 2007), making insight an important target for
treatment.
Evidence suggests that treatment with antipsychotic drugs leads to
increased insight, although this effect may be limited to the early
phase of treatment (Pijnenborg et al., 2015). Alternatively, though in-
sight may be increased through psychosocial interventions, substantial
improvement of treatment options remains (Pijnenborg et al., 2013).
For example, cognitive behavioral therapy, psycho-education and ad-
herence therapy did not significantly improve insight in the small trials
that have been conducted to date. Preliminary evidence does exist for a
comprehensive intervention aiming to decrease self-stigma that im-
proved insight (Fung et al., 2011). Integrating such approaches into
363G.H.M. Pijnenborg et al. / Schizophrenia Research 206 (2019) 362–369one targeted cognitive-behavioral treatment aimed at increasing insight
may thus be effective.
In this study, a new theory-driven intervention aiming to increase
clinical insight in schizophrenia was evaluated. The intervention (RE-
FLEX)was based on an integrativemodel of insight (Fig. 1) that summa-
rizes factors contributing to poor clinical insight in psychotic disorders
(Pijnenborg et al., 2011). Clinical insight has been distinguished from
cognitive insight and refers to the awareness of having a mental illness,
being able to recognize the symptoms thereof and recognizing the need
for treatment (David, 1990). Cognitive insight involves patients' ability
to evaluate or distance themselves from anomalous experiences and er-
roneous inferences (Beck et al., 2004) and is conceptualized as a combi-
nation of self-reflection and self-certainty. Although literature on the
relationship between cognitive insight and clinical insight is inconsis-
tent (David et al., 2012), hypo-activation in brain areas traditionally as-
sociated with self-reflection was found in relation to both poor clinical
and poor cognitive insight (Van Der Meer et al., 2013).
This suggests that self-reflection is highly relevant for both clinical
and cognitive insight (Van der Meer et al., 2012). Therefore, the associ-
ation between self-reflection and insight is central to the model: poor
insight is considered the outcome of impaired self-reflection. Self-
reflection is thought to mediate the relationship between impaired in-
sight and factors that have been proposed as preconditions of poor in-
sight: perspective taking (Langdon and Ward, 2009), stigma
sensitivity (Cooke et al., 2005; Lysaker et al., 2005) and neurocognition
(Mintz et al., 2003). Neurocognitive deficits may limit a patient's ability
to consider alternative viewpoints and the integration of outside infor-
mation. This may in turn limit the patient's ability to understand that
he or she has an illness (Riggs et al., 2012) and may lead to an inability
to incorporate mental health problems into a personal narrative (Buck
et al., 2009). Especially Theory of Mind was found to be associated
with insight; being able to see the world from the perspective of others
is associated with a better understanding of one's own mind
(Pijnenborg et al., 2013; Vohs et al., 2016).
Importantly, a factor that needs to be considered in the develop-
ment of an intervention aiming at increasing insight is self-stigma
(Belvederi et al., 2015). Patients with poor insight often show poorer
social functioning, are less adherent and have more symptoms, while
patients with good insight are more often depressed and report
lower quality of life (Olfson et al., 2006; Francis and Penn, 2001;
Kvrgic et al., 2013; Hasson-Ohayon et al., 2006; Hasson-Ohayon
et al., 2009). This phenomenon is known as the insight paradox
(Lysaker et al., 2007) with evidence suggesting that its self-stigma
moderates the relationship between insight and outcomes (Lysaker
et al., 2007). People with high self-stigma tend to get more depressed
when insight is better.Fig. 1. PreconditioIn sum, REFLEX aims to improve insight by targeting self-reflection,
perspective taking and stigma-sensitivity. During the intervention peo-
ple are encouraged to reconstruct their own personal narrative, includ-
ing their mental health problems (Lysaker et al., 2010). Because of the
mediation effect of self-stigma, stigma sensitivity is an additional target
in the intervention.
1.1. Aims of the study
The aim of this study was to evaluate the effectiveness of REFLEX as
an intervention for improving insight in people with schizophrenia.
REFLEX was compared to an active control condition consisting of
group-wise simplified drill-and-practice cognitive remediation training
(simplified CRT). The primary objective was to improve clinical insight
by stimulating its preconditions. Given their associations with insight,
we expected mood, self-esteem and quality of life to improve as well.
2. Experimental/materials and methods
2.1. Subjects
A total number of 121 patients were recruited in seven mental
health care centers in the Netherlands (see Table 1 for demographic
and clinical variables). Inclusion criteria were: 1) having a diagnosis of
schizophrenia established by the Mini International Neuropsychiatric
Interview-Plus 5.0.0. (MINI-Plus; Sheenan et al., 1998), a semi-
structured interview to assess DSM-IV pathology; 2) having impaired
insight, indicated by a score of ≤9 on the Psychosis Inventory
(Birchwood et al., 1994) and established by a clinician's rating defined
as one or more non-affirmative answers on three questions assessing
awareness of mental illness, recognition of symptoms and acknowledg-
ing need for treatment. In case of an inconsistency between these two, a
Positive and Negative Syndrome Scale interview (PANSS; Kay et al.,
1987) was administered. Patients with scoring N3 on item G12 (mean-
ing at least a mild degree of impaired insight) were considered eligible
for the trial; 3) age N 18 and 4) being able to give informed consent. Ex-
clusion criteria were 1) receiving cognitive behavioral therapy 2) an
acute episode of psychosis 3) a co-morbid neurological disorder. All pa-
tients received treatment as usual (TAU) in addition to REFLEX or CRT,
according to Dutch clinical guidelines that are in line with the interna-
tional NICE guidelines.
2.2. Procedure
Potentially eligible patientswere referred by their treating clinicians.
Study procedures were explained and patients were given a reflectionns of insight.
Table 1





Age (mean, Sd) 38.55 (12.66) 40.82 (10.81)
Gender (% men) 87.1⁎ 70.0
Level of education (mean, Sd) 5.13 (1.22) 4.97 (1.16)
Number of psychotic episodes (mean, Sd) 3.68 (4.04)
Chronic
psychotic




symptoms: n = 4
Years of illness (mean, Sd) 11.32 (9.12) 14.06 (10.39)
Baseline PANSS pos (mean, Sd) 15.70 (4.42) 15.88 (4.40)
Baseline PANSS neg (mean, Sd) 14.63 (5.29) 14.54 (5.10)
Baseline PANSS gen (mean, Sd) 32.25 (7.91) 32.17 (6.17)
Antipsychotic medication (%, n)
Dipiperon 0% (0) 1.7% (1)
Olanzapine 14.5% (9) 36.7% (21)
Clozapine 33.9% (21) 30% (17)
Paliperidon 1.6% (1) 3.4% (2)
Risperidon 20.8% (13) 8.5% (5)
Quetiapine 4.8% (3) 11.9% (7)
Pimozide 1.6% (1) 0% (0)
Aripiprazol 11.2% (7) 10.2% (6)
Cisordinol 1.6% (1) 6.8% (4)
Haloperidol 4.8% (3) 5.1% (3)
Bromperidol 0% (0) 1.7% (1)
Anti-depressants 14.5% (9) 10.2% (6)
Mood-stabilizers 9.6% (6) 5.1% (3)
Tranquilizers 30.6% (19) 22.0% (13)
Inpatient 9.7% (6) 10.2% (6)
Outpatient 62.9% (39) 66.1% (39)
Sheltered housing 27.4% (17) 23.7% (14)
Clinical insight (mean, Sd)
SAI-E interview 11.84 (4.4) 11.50 (4.9)
SAI-E clinician 6.22 (2.5)⁎ 7.31 (2.2)
PANSS G-12 3.81 (1.2) 3.81 (1.1)
Cognitive insight/self-reflection (mean,
Sd)
BCIS self-reflectiveness 23.85 (3.6)⁎ 21.8 (4.1)
BCIS self-certainty 14.60 (3.3) 14.15 (2.9)
S-RIS total 72.42 (10.1) 71.95 (9.3)
BCIS cognitive insight 6.26 (4.7)⁎ 4.68 (5.3)
Perspective taking (mean, Sd)
DACOBS (ToM) 23.92 (5.3) 24.0 (5.6).
Self-stigma (mean, Sd)
ISMI total 63.52 (17.4) 61.95 (9.9)
Depression (mean, Sd)
QUID-Sr 3.84 (1.8) 4.14 (1.7)
Self-esteem (mean, Sd)
SERS pos 46.21 (10.4) 47.37 (10.6)
SERS neg 31.08 (10.9) 32.22 (10.8)
Quality of life (mean, Sd)
MANSA 58.13 (9.9) 58.17 (9.2)
Symptoms (mean, Sd)
PANSS pos 18.74 (6.2) 18.16 (5.2)
PANSS neg 12.94 (5.8) 12.31 (5.3)
PANSS des 21.69 (6.7) 22.17 (5.9)
PANSS exc 12.87 (3.8) 12.80 (3.2)
PANSS emo 16.60 (4.9) 16.45 (3.9)
A scale (Verhage, 1964) ranging from 1=primary school (6 years of formal education) to
7 = university (16 years of formal education).
⁎ p b .05.
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tained. Subsequently, diagnosis was verified by the researchers with
the Mini Plus. Randomization procedures were started when the opti-
mal number of patients per center (ranging from 17 to 19) was in-
cluded, or, when the first patient was included more than six weeks
ago, while N10 people were included.
All patients were assessed at baseline (T0), directly post-treatment
(T1) and sixmonths post-treatment (T2) by trained research assistants,
blind to randomization status. Treatment fidelity was monitored aftertraining session. The trial complied with the declaration of Helsinki,
was approved by the Institutional Review Board of the UMCG and reg-
istered in the trial register ‘current controlled trials’ (ISRCTN50247539).2.3. Materials
2.3.1. Intervention
2.3.1.1. REFLEX. REFLEX encompasses three modules of four one-hour
group sessions each. Module I “Coping with Stigma” focuses on coping
with stigmatizing beliefs. The impact of stigmatizing beliefs is discussed
and stigmatizing beliefs are disputed and replaced with functional
reality-based beliefs about the self. Patients learn that a diagnosis is
just a label, saying little about them. The goal of this module is twofold:
first, we presume that denial to cope with the threat that mental illness
poses on the self-esteem will be less necessary when the idea of having
a mental illness is perceived as less threatening. Following this train of
thought, challenging stigmatizing beliefs will ultimately contribute to
better insight. Second, with the inclusion of the stigma module we
want to prevent an increase of depression to co-occurwith increasing in-
sight, as literature has shown that stigma mediates the relationship be-
tween insight and mood. In the module “You and your personal
narrative” self-reflection is the central theme. Subjects reconstruct their
personal narrative, reflect on important changes in their lives and their
personal strengths andweaknesses. By offering very structured exercises
with clear instructions, REFLEX compensates for cognitive impairments
that are thought to hamper self-reflection in schizophrenia. In this mod-
ule, subjects start practising perspective-taking. Subjects are instructed
to ask themselves on a regular basis what other people would think
about their thoughts and to check this with an important other. In the
third module, called “You in the present”, reflection about ongoing
thoughts and feelings is stimulated. Between sessions, subjects monitor
their thoughts and feelings in their daily life by experience-sampling
(Myin-Germeys et al., 2009). In response to a random signal (beeping
of a watch) provided six times a day, patients write down the answer
to a fixed number of short questions that stimulate self-reflection in a
diary. Examples of these questions are: “what was I thinking about be-
fore the alarm went off?” and “what would other people think about
this thought?”. During group sessions, the content of these dairies is
discussed. In addition, group exercises and movie vignettes are used to
practice perspective-taking during treatment sessions.2.4. Control condition
The protocolized control condition consists of twelve one-hour
group sessions of standardized ‘drill-and-practice’ exercises. Instruc-
tions were provided by master students in psychology. Most ‘pen-
and-paper’ exercises were adopted from Cognitive Remediation Train-
ing protocol (Delahunty and Morice, 1996). Exercises explicitly stimu-
lating mental flexibility were removed, as these showed a relationship
with insight in psychoses in a meta-analysis (Aleman et al., 2006). To
prevent participants from gaining more insight in their own perfor-
mance, trainers did not provide any feedback.2.4.1. Instruments
2.4.1.1. Screening. Psychosis Insight Scale (PI, Birchwood et al., 1994): an
eight item self-report questionnaire, consisting of three subscales: aware-
ness of illness; relabeling symptoms to illness, and need for treatment.2.4.1.2. Classification. MINI-plus (Sheenan et al., 1998): a structured in-
terview to asses axis I disorders according to DSM IV and ICD 10 criteria.
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Stigma sensitivity:
The Internalized Stigma of Mental Illness Scale (ISMI; Ritscher et al.,
2003): a self-rating questionnaire measuring the subjective experience
of stigma (29 Likert-scale items).
Self-reflection:
The Self-Reflection and Insight Scale (S-RIS; Grant et al., 2002): a self-
rating questionnaire measuring ‘Need for self-reflection’, ‘Engagement
in Self-reflection’ and ‘Insight’ (20 Likert-scale items).
Subscales of the Beck Cognitive Insight Scale (BCIS; Beck et al., 2004): a
self-rating questionnaire evaluating patients' self-reflectiveness and id-
iosyncratic self-certainty. The scale consists of 15-items, divided into
two subscales: self- reflectiveness (9 items) and self-certainty (6 items).
Perspective-taking:
The Theory of Mind subscale of the Davos Assessment of Cognitive
Biases Scale (DACOBS; Van der Gaag et al., 2013): 42-item Likert self-
rating scale that measures cognitive biases and safety behavior in psy-
chosis. The social cognitive problems subscale was used to assess
perspective-taking.
2.4.1.4. Clinical insight and cognitive insight (secondary outcomes). Sched-
ule for Assessment of Insight-Expanded (SAI-E;Amador et al., 1993): a 12-
item semi-structured interview to assess insight, based on David's three
dimensions of insight. The SAI-E takes both the opinion of the inter-
viewer and the clinician into account. The SAI-E was divided into two
variables: SAI-E Interview (questions 1–9) and SAI-E Rater (questions
A, B and C).
Item G12 of PANSS (Kay et al., 1987): Item G12 of the PANSS assesses
insight in psychosis and is highly correlated with other insight mea-
sures, such as the SAI, SAI-E and ITAQ.
The Beck Cognitive Insight Scale (BCIS; Beck et al., 2004): a self-rating
questionnaire evaluating patients' self-reflectiveness and idiosyncratic
self-certainty. The scale consists of 15-items, divided into two subscales:
self- reflectiveness (9 items) and self-certainty (6 items). The delta of
this items represents cognitive stigma.
2.4.1.5. Other outcome measures.Depression:
The Quick Inventory of Depressive Symptomatology Self-Report (QIDS-
SR; Rush et al., 2003) is a 16-item self-report questionnaire that rates
depressive symptoms according to the DSM-IV in the week before as-
sessment. The QIDS-SR has been validated for patients with schizophre-
nia (Ma et al., 2015).
Self-esteem:
The Self-Esteem Rating Scale-Short Form (Lecomte et al., 2006) is a
self-report questionnaire measuring self-esteem encompassing state-
ments linked to social contacts, achievement and competency and vali-
dated for people with schizophrenia. The SERS has two 10-item
subscales: positive and negative self-esteem.
Quality of Life:
The self-ratingManchester Short Assessment of Quality of Life (MANSA;
Priebe et al., 1999): TheMANSA is a self-report questionnaire containing
four objective questions and twelve subjective questions on satisfaction
with life as a whole (16 Likert-scale items).
Symptoms:
Positive and Negative Syndrome Scale (PANSS; Kay et al., 1987). This
semi-structured interview was employed by trained raters to indicatethe severity of 30 symptoms of psychosis on five scales (Van der Gaag
et al., 2006): positive symptoms, negative symptoms, disorganization,
excitement, and emotional distress using a seven-point Likert scale,
ranging from ‘Absent’ to ‘Extreme’.
Unless indicated otherwise, total scores are used in the analyses.
2.5. Statistical analyses
To examine whether randomization was successful, differences in
baseline demographical and disease variables were tested. A X2−tests
was applied for gender, and independent sample t-test with condition
as independent variable were applied to test for differences in age,
level of education, duration of illness, living situation/treatment type
and PANSS total respectively. Tests were two-tailed, with significance
levels set at p b .05. Variables that significantly differed between condi-
tions were entered as covariates in subsequent analyses.
To compare the effects of REFLEX on the study's outcomes, multi-
level modeling was applied. MLwinN (Rasbash et al., 2005) was used
to build a 2-levelmodel for each of the dependent variables, where sub-
jects were modelled at level 2 and time of assessment at level 1. Fixed
predictors were: a) intercept and dummy variables representing time
(T0, T1, T2); b) condition; c) the interaction term time*condition. As
random effects, we included the random intercept at level 2 and the re-
sidual variance at level 1. Statistical significance of fixed effects were
tested using the approximate t-test, and of random effects using the de-
viance test, with a significance level set at p b .05. First, an intention to
treat (ITT) analysis on the entire sample was performed. Subsequently,
we performed a sensitivity analysis including only participants who
attended more than six group sessions (N50% of the training). Finally,
to examine the effects of REFLEX on insight over and above that of an
overall symptom-level at each measurement occasion, the overall
symptom-level except insight was included (PANSS minus item G12).
3. Results
Of the demographic and disease variables, only gender differed sig-
nificantly between groups at baseline, with significantly more men in
the control condition (X2 df = 1, 5.32, p b .05, see Table 1), thus gender
was entered as a covariate in further analyses. Drop-out rates were
comparable between conditions (see Fig. 2 for a detailed flow chart of
all inclusions and drop-outs).
There was a significant difference in the number of sessions patients
attended (t = 2.14, df = 119, p b .05, 95% c.i. 0.12–3.07): the mean
number of sessions in the control group was 7.31 (Sd 4.6), and in the
REFLEX condition 8.90 (Sd 3.5).
3.1. Randomization
Patients in the control condition had significantly lower clinician
rated insight at baseline (t = 2.20, df = 109, p b .05) and scored signif-
icantly higher on BCIS self-reflection and BCIS cognitive insight at base-
line (t = 3.26, df = 115, p b .001; t = 2.67, df = 115, p b .01). There
were no other baseline differences (see Table 1).
3.2. Intention to treat analyses
3.2.1. Preconditions of insight: cognitive insight/self-reflection/perspective
taking/self-stigma
There was no significant increase of cognitive insight/self-reflection
(BCIS self-reflection/BCIS self-certainty/S-RIS total), and social cognition
(DACOBS) in either condition between baseline and post-treatment
(BCIS self-reflection: t = 0.99, df = 115, n.s.; BCIS self-certainty: t =
0.71, df = 115, n.s.; S-RIS total: t = 0.40, df = 115, n.s.; DACOBS social
cognitive problems: t = 0.58, df = 115, n.s.) or between baseline and
follow-up (BCIS self-reflection: t = 0.99, df = 115, n.s.; BCIS self-
certainty: t = 0.36, df = 115, n.s.; S-RIS total: t = 0.76, df = 115, n.s.,
Fig. 2. Flow chart. 6.8% dropped out of the REFLEX condition and 11.7% of the control condition.
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between baseline and follow-up over both conditions (DACOBS social
cognitive problems t = 3.01, df = 115, p b .005). Self-stigma showed
a small, non-significant decrease post-treatment (ISMI baseline-post-
treatment: t=1.48, df=115, n.s.).While therewas no significant over-
all difference between baseline-and follow-up (t= 0.56, df= 115, n.s.),
self-stigma returned to baseline in the REFLEX condition but decreased
significantly further in control condition (ISMI baseline-follow-
up*condition t = 1.94, df = 115, p b .05).3.2.2. Insight
3.2.2.1. Clinical insight. Clinical insight improved significantly in both
conditions (see Fig. 3 and Table 2 for statistical details). Clinical insight
assessed with SAI-E Rater and PANSS-G12 was significantly better
post-treatment than at baseline and significantly better at follow-up
than at baseline for all three clinical insight measures. Patients in the
REFLEX condition improved significantly more than in the control con-
dition on clinician-rated insight, this interaction effect disappeared at
Table 2
Post-training and follow-up assessment (intention to treat analyses).
Post-training Follow-up
Control REFLEX Control REFLEX
Clinical insight (mean, Sd) SAI-E interview 12.14 (5.5) 12.40 (6.2) 14.96 (5.4) 14.90 (5.2)
SAI-E clinician 6.43 (3.0) 8.31 (2.4) 8.23 (2.5) 8.68 (2.3)
PANSS G-12 3.18 (1.2) 3.31 (1.4) 2.74 (1.2) 2.71 (1.4)
Cognitive insight/self-reflection (mean, Sd) BCIS self-reflectiveness 23.65 (4.4) 22.31 (3.9) 23.57 (4.5) 21.95 (3.5)
BCIS self-certainty 14.04 (3.82) 14.37 (2.9) 13.88 (3.6) 13.60 (2.8)
S-RIS total 73.0 (8.1) 72.83 (9.6) 70.27 (7.9) 71.36 (7.7)
BCIS cognitive insight 6.56 (6.2) 5.01 (5.2) 6.53 (5.1) 5.01 (4.5)
Perspective taking (mean, Sd) DACOBS (ToM) 23.61 (6.0) 22.78 (6.2) 22.17 (5.8) 23.19 (4.9)
Self-stigma (mean, Sd) ISMI total 60.47 (8.5) 59.90 (9.8) 58.67 (9.7) 60.07 (9.6)
Depression (mean, Sd) QUID-SR 3.68 (1.9) 3.71 (1.9) 3.62 (1.8) 4.02 (1.9)
Self-esteem (mean, Sd) SERS pos 47.59 (11.1) 49.05 (10.9) 46.83 (11.1) 47.17 (9.3)
SERS neg 29.6 (9.5) 30.65 (10.2) 28.86 (10.7) 31.74 (9.9)
Quality of life (mean, Sd) MANSA 56.88 (10.7) 58.75 (9.3) 57.91 (10.3) 58.25 (9.8)
Symptoms (mean, Sd) PANSS pos 16.22 (6.5) 15.67 (5.6) 16.02 (6.0) 14.23 (5.5)
PANSS neg 11.84 (6.0) 11.47 (4.6) 10.87 (5.4) 11.23 (4.8)
PANSS des 20.38 (6.1) 19.67 (5.9) 20.38 (6.2) 19.86 (6.1)
PANSS exc 12.58 (4.3) 11.85 (3.0) 13.02 (4.9) 12.33 (3.3)
PANSS emo 14.62 (4.7) 15.01 (4.6) 16.11 (5.1) 15.23 (4.9)
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significant.
3.2.2.2. Cognitive insight. Cognitive insight remained stable over time be-
tween baseline and post-treatment (t = 0.99, df = 115, n.s.) and be-
tween baseline en follow-up (t = 0.60, df = 115, n.s.).
3.2.2.3. Depression, self-esteem, symptoms and quality of life.Quality of life
was increased post-treatment in both conditions (MANSA (t=3.05, df=
115, p b .01). Self-esteem and depression remained stable over time,
there were no significant differences between conditions (baseline-
post-treatment: self-esteem: SERS-pos t = 1.28, df = 115, n.s.; SERS
neg t = 0.89, df = 115, n.s.; depression: QUID-SR t = 1.42, df = 115,
n.s; quality of life: MANSA t = 0.72, df = 115,n.s.; PANSSpos t = 0.57,
df = 115, n.s.; PANSSneg t = 0.34, df = 115, n.s.; PANSSdes t = 0.57,
df = 115, n.s.; PANSSemo t = 0.75, df = 115, n.s.; PANSSexc t = 0.09,
df = 115, n.s.) and baseline-follow-up: self-esteem: SERS-pos t =
0.16, df = 115, n.s.; SERS neg t = 0.09, df = 115, n.s.; depression:
QUID-SR t = 0.30, df = 115, n.s; quality of life: MANSA t.13, df = 115,
n.s.; PANSSpos t = 0.96, df = 115, n.s.; PANSSneg t = 0.32, df = 115,
n.s.; PANSSdes t = 0.96, df = 115, n.s.; PANSSemo t = 0.38, df = 115,
n.s.; PANSSexc t = 0.27, df = 115, n.s.).Fig. 3. Improvement of clinical insight over time per condition3.3. Sensitivity analyses and controlling for overall symptom-level
Results of the sensitivity analyses did not change the implications of
the results of the intention-to-treat analyses, nor did controlling for
overall symptom level at each occasion (T0-T2).4. Discussion
Themainfindingof this study is that both REFLEX and simplified CRT
resulted in significantly improved clinical insight. Several studies have
shown that while clinical insight improves with pharmacological treat-
ment in the first phase of illness, it is relatively stable in non-recent
onset patients receiving treatment as usual (Pijnenborg et al., 2013;
Van Baars et al., 2013). Given that the large majority of the patients in
this trial had been ill for several years, the improvement in insight we
found in both conditions is not likely to be simply an effect of time.
The fact that subjective quality of life improved significantly in both
conditions refutes the idea that improving insight leads to low mood.
Our primary outcomes, the preconditions of insight, that were ex-
pected to mediate insight change, remained stable in both conditions.
Although the mechanisms underlying changes need further research,
REFLEX stimulated clinical insight. This has consequences for our
model: changes in clinical insight are possible without changes in its
preconditions. Possibly, specific elements of REFLEX, such as challeng-
ing dysfunctional beliefs about diagnostic labels and reflecting on the
impact of symptoms in daily life have directly stimulated clinical insight.
Although this is not necessarily evidence against a relationship between
perspective taking, self-reflection, and stigma sensitivity with clinical
insight, it may be that the supposed mediators are in fact more stable
measures of personal style.
In contrast with our expectations, REFLEX did not decrease self-
stigma. Baseline self-stigma was low, leaving little room for improve-
ment. This may have been an effect of our recruitment strategy that
was based on impaired insight: people with impaired insight report
less self-stigma (Schrank et al., 2013). A meta-analysis on interventions
that reduce self-stigma in mental illness had mixed results, probably
due to methodological limitations of these studies and heterogeneity of
the interventions and low statistical power of the meta (Büchter and
Messer, 2017). Results for NECT, an intervention addressing self-stigma
(Yanos et al., 2012) that was very comparable to REFLEX in combining
psycho-education and cognitive restructuring with narrative enhance-
ment (focusing on sharing and telling personal narratives about oneself
and one's mental illness) were mixed, with the first study not showing
a difference in insight and self-stigma between the intervention and
368 G.H.M. Pijnenborg et al. / Schizophrenia Research 206 (2019) 362–369TAU, while a recent study onNECT in a larger sample did find an effect of
the intervention on self-stigma (Hansson et al., 2017). Thus, it would be
preliminary to conclude that narrative enhancement cannot decrease
self-stigma. Another intervention focusing on identity enhancing is
Photovoice (Russinova et al., 2014). Photovoice is a manualized peer-
led intervention, inwhich photos andnarratives corresponding to coping
with psychiatric illnesses are discussed in a group. Moreover, psycho-
education on stigma is offered in combination with exercises aiming to
strengthen identity. In contracts to REFLEX, Photovoice was effective in
reducing self-stigma. Effective elements of Photovoice, compared to
REFLEX, may have been the use of non-verbal material with a personal
meaning or the interaction with peers.
Together with our own findings the conclusion that stimulating per-
sonal narratives does not lead to decreased self-stigma seems justified.
When developing this study, we considered the active control condition
a strength of the design, as it controls for “general” treatment effects.
However, the active control conditionmay have had unexpected effects
on insight. This could be due to a-specific elements that both interven-
tions have in common. Alternatively, specific elements of CRT may lead
to an increase of insight. Indeed a meta-analysis showed an association
of clinical insight and basic cognitive skills (Nair et al., 2014). In linewith
this, a clinical trial (Lalova et al., 2013) that compared training of basic
cognitive processes, autobiographicalmemory, andmetacognitive func-
tions showed that each of these interventions was associated with im-
proved clinical insight. Since we did not expected REFLEX to have an
effect on neurocognition, this was not included as an outcome. There-
fore, we cannot definitely conclude that insight-change in the CRT con-
dition was precluded by improved cognitive functioning. Alternatively,
a-specific elements of both interventions, such as weekly peer-to-peer
contact and working on structured assignments together with others
with the same diagnosis, may have been responsible for increased in-
sight. The significantly higher attendance rate for REFLEX over CRT
may indicate that patients preferred this intervention.
REFLEX did not increase cognitive insight. This finding is in linewith
the effects of another study on the effects of a training focusing on social
cognition in psychotic disorders on cognitive insight (Tas et al., 2012).
Scores on the self-certainty subscale of the BCIS even decreased after
this training. However, there was no effect of this training on the BCIS
composite index, nor on the self-reflection subscale (Tas et al., 2012).
Moreover, another recent clinical trial evaluating a self-reflection train-
ing for people with schizophrenia also failed to find an effect on cogni-
tive insight (Jørgensen et al., 2014).
Recently, Vohs et al. (2016) published an integrative model of in-
sight, that largely overlaps the model of insight on which REFLEX was
based (Pijnenborg et al., 2011), and addedmeta-cognition as a predictor
of poor self-reflectivity. Metacognition here refers to activities that
allow people to be aware of and form complex representations of self
and others and might be a target for psychotherapy.
Indeed, ametacognitive therapy (MERIT) for psychoseswas found to
have a positive effect on insight in a first episode sample (Vos et al., in
press). MERIT stimulates metacognitive capacity defined as a spectrum
ofmetacognitive activities that involve thinking about thinking, ranging
fromdiscrete acts, in which people recognize specific thoughts and feel-
ings, to more synthetic acts, in which an array of intentions, thoughts
and feelings and connections between events are integrated into larger
complex representations (Lysaker et al., 2013). Perhaps focussing on
these more integrative aspects of social processes is necessary to im-
prove insight.
4.1. Limitations
This study has several limitations. First, insight was assessed as
knowledge about one's mental health problems, or, in other words, as
a relatively isolated set of cognitions. This operationalization of insight
does not take in to account the fact that awareness of illness is an inex-
tricable part of a personal narrative (Lysaker et al., 2010). It may be thatassessing insight in a more narrative way would have been more sensi-
tive to the specific effects of REFLEX. Second, self-reflection and per-
spective taking were assessed with self-report. This may have masked
effects on these outcomes. Jørgensen et al. (2014) found that training
self-reflection in psychotic disorders was even associated with a de-
crease in cognitive insight. May be increased insight leads to more real-
istic scores, i.c. most often lower scores on self-report. Third, in contrast
with PANSS-raters, clinicians who completed the SAI-E items for clini-
cians were not blind, which may have influenced their scores.
5. Conclusion
Although REFLEX was composed to address specific aspects of in-
sight, it's effects were not superior to that of simplified CRT. Insight
may have been improved by TAU and common non-specific factors
such as group meetings and exercises in both conditions, but also be
specific elements of both therapies. Since insight is unlikely to improve
spontaneously in chronic patients, further research on their underlying
mechanisms is needed.
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